MacroGenics (MGNX) Peer Comparison

$4.06

$-0.02 (-0.49%)

As on 28-Aug-2026 13:34EDT

Market cap

$261 Mln

Revenue (TTM)

$168 Mln

P/E Ratio

--

P/B Ratio

6.1

Div. Yield

0 %

Edit

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	261	17,326	16,614	13,400	12,305
Revenue ($ Mln)	168	2,782	1,054	2,436	670
Net Profit ($ Mln)	-14.59	491.50	755.85	860.62	-319.95
Net Margin (%)	-8.70	17.67	71.69	35.33	-47.79
RoE (%)	-29.64	110.09	--	42.98	-71.14
Price to Earnings	--	36.49	19.38	17.01	--
Price-To-Book	6.09	39.43	10.05	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	167.67	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	83.10	1,982.07	103.47	85.67	19.14
Gross Profit	106.32	760.62	588.53	2,236.43	829.45
Operating Expenses	172.01	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-40.75	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-104.53	598.92	101.11	1,035.47	-252.08
Provision for Tax	-89.93	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-14.59	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	42.87	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	193.72	187.89	384.48	288.55	1,362.63
Current Liabilities	108.82	1,435.43	464.70	361.93	283.35
Total Liabilities	256.85	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	23.72	1,006.90	895.24	1,243.41	440.60
Current Assets	321.69	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	256.85	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	35.09	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-81.04	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-114.10	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	69.51	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-47.25	53.56	-30.01	32.82	-0.17
ROE (%)	-29.64	110.09	163.18	42.98	-71.14
ROA (%)	-3.07	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-52.26	21.13	5.73	31.04	-0.77
Net Margin (%)	-8.70	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	2.32	24.67	114.85	9.23	12.22
EBIT Growth (%)	-154.13	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	59.91	17.50	378.76	42.89	-115.58
EPS Growth (%)	59.92	26.84	353.27	50.42	-73.87
Book Value Growth (%)	-8.70	164.02	816.12	-0.70	-13.57

Valuation Ratios

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-1.36	36.06	-59.76	15.79	-2,869.63
Price / Book Value	1.83	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-0.31	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.12	0.00	0.05	0.00	0.09
Current Ratio	2.96	0.73	2.99	3.46	5.90
Quick Ratio	2.96	0.73	2.32	3.38	5.90
Interest Coverage	-5.19	--	1.62	--	-1.72

Operating Efficiency Ratios

	MacroGenics (MGNX)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	85.98	15.88	21.25	13.74	1.28
Asset Turnover	0.35	0.89	0.37	0.83	0.34
Receivable days	21.60	50.42	85.52	43.48	1.50
Inventory Days	33.45	--	1,056.70	96.17	--
Payable days	41.45	6.26	331.01	147.97	221.81
Cash Conversion Cycle	13.61	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly